EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Microfluidic platforms for precision delivery of therapeutic cells in regenerative and personalized medicine

Maryam Sadat Mirlohi, Shima Akar, Kaveh Yazdani, Hamed Alizadeh Sardroud, Somayeh Fardindoost, Mahdokht Akbari Taemeh, Maya Achuthan, Sanjana Singh, Glen Tibbits, Jamshid Hadjati, Colin Collins, Mina Hoorfar und 2 weitere

Advanced Drug Delivery Reviews · 2026-07 · 234 · 115865

DOI: 10.1016/j.addr.2026.115865 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2026-07. Verfasst von Maryam Sadat Mirlohi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Mechanical Engineering Department, University of Victoria, Victoria, BC, Canada. Hauptthemen laut MEDLINE: Regenerative Medicine, Precision Medicine, Microfluidics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 470 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regenerative medicine increasingly relies on therapeutic cells such as mesenchymal stem cells and induced pluripotent stem cells, and engineered cellular constructs to repair and restore damaged tissues. However, clinical translation is constrained by challenges in maintaining viability, ensuring precise localization, achieving durable engraftment of transplanted cells, and producing sufficient numbers of clinically relevant cells. Microfluidic technologies are emerging as transformative tools to address these barriers by enabling precise manipulation of fluids, biomaterials, and cells at the microscale. In the context of therapeutic cell delivery, these platforms can improve early retention and engraftment compared with conventional injections, provide tighter control over delivered cell dose, preserve viability under defined shear conditions, enable site-specific placement of cell-laden carriers, and support immunoisolating or immunomodulatory architectures that enhance immune safety. These platforms provide controlled microenvironments that mimic native tissue architecture, regulate biochemical and mechanical cues, and support the scalable production of cell-laden carriers. Advances in microfabrication techniques, ranging from soft lithography and thermoplastics to 3D printing and hydrogel integration, have expanded device versatility, while embedded sensors enable real-time monitoring of cell state, metabolism, and differentiation. Beyond single-cell delivery, microfluidics facilitates the encapsulation, co-culture, and organoid assembly of cells, enabling multicellular systems with physiologically relevant interactions. Coupled with CRISPR-based genome editing and synthetic biology, these platforms allow the engineering of "smart" therapeutic cells with enhanced regenerative and immunomodulatory functions. Applications extend to microfluidic sorting for stem cell purification, controlled differentiation, and advanced manufacturing of immune cell therapies such as chimeric antigen receptor (CAR)T cells, alongside exosome-based strategies for precision delivery. Despite promising progress, challenges remain in regulatory standardization, large-scale manufacturing, and integration with clinical workflows. This review highlights state-of-the-art microfluidic approaches for controlled delivery of stem cells and engineered cells, emphasizing how these systems impact key delivery metrics such as retention, dose control, shear resilience, spatial targeting, and immune interfaces to advance precision regenerative medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Regenerative MedicinePrecision MedicineMicrofluidicsHumansAnimals

Stichwörter der Autor:innen

Adaptive transferDrug Delivery SystemsMicrofluidicsOrgans on chipStem cells

Autor:innen und Institutionen

  • Mechanical Engineering Department, University of Victoria, Victoria, BC, Canada.
  • School of Biomedical Engineering, University of British Columbia, Vancouver, BC, Canada.
  • Cellular and Regenerative Medicine Centre, BC Children's Hospital Research Institute, Vancouver, BC, Canada.
  • Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Mechanical Engineering Department, University of Victoria, Victoria, BC, Canada. Electronic address: makbari@uvic.ca.

Förderung

  • Natural Sciences and Engineering Research Council of Canada

Zitieren

APA

Mirlohi, M. S., Akar, S., Yazdani, K., Alizadeh Sardroud, H., Fardindoost, S., Taemeh, M. A., Achuthan, M., Singh, S., Tibbits, G., Hadjati, J., Collins, C., Hoorfar, M., Karimi, M. H., & Akbari, M. (2026). Microfluidic platforms for precision delivery of therapeutic cells in regenerative and personalized medicine. Advanced Drug Delivery Reviews, 234, 115865. https://doi.org/10.1016/j.addr.2026.115865

Vancouver

Mirlohi MS, Akar S, Yazdani K, Alizadeh Sardroud H, Fardindoost S, Taemeh MA, et al. Microfluidic platforms for precision delivery of therapeutic cells in regenerative and personalized medicine. Advanced Drug Delivery Reviews. 2026;234:115865. doi:10.1016/j.addr.2026.115865

BibTeX
@article{Mirlohi2026,
  author = {Mirlohi, Maryam Sadat and Akar, Shima and Yazdani, Kaveh and Alizadeh Sardroud, Hamed and Fardindoost, Somayeh and Taemeh, Mahdokht Akbari and Achuthan, Maya and Singh, Sanjana and Tibbits, Glen and Hadjati, Jamshid and Collins, Colin and Hoorfar, Mina and Karimi, Mohammad Hossein and Akbari, Mohsen},
  title = {Microfluidic platforms for precision delivery of therapeutic cells in regenerative and personalized medicine},
  journal = {Advanced Drug Delivery Reviews},
  year = {2026},
  volume = {234},
  pages = {115865},
  doi = {10.1016/j.addr.2026.115865}
}
Kostenlos starten →